Search research articles
Contact Us
Filters
Showing results (111-120 of 1,990) with videos related to
Page
of 199
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1994
Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether
U Köster, P Speerschneider, R Kerssebaum, et al.
Chemical Research in Toxicology
|
July 22, 1998
Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1,2,3,4, 4-pentachlorobutadienyl)-L-cysteine sulfoxide
G Birner, M Werner, E Rosner, et al.
Chemico-Biological Interactions
|
August 14, 1992
Glutathione depletion, lipid peroxidation, DNA double-strand breaks and the cytotoxicity of 2-bromo-3-(N-acetylcystein-S-yl)hydroquinone in rat renal cortical cells
S Vamvakas, D Bittner, M Koob, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1994
Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)
G D Loizou, G Urban, W Dekant, et al.
Biochemical Pharmacology
|
January 15, 1986
Mutagenicity of chloroolefins in the Salmonella/mammalian microsome test--II. Structural requirements for the metabolic activation of non-allylic chloropropenes and methylated derivatives via epoxide formation
T Neudecker, W Dekant, M Jörns, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1987
Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation
W Dekant, G Martens, S Vamvakas, et al.
Carcinogenesis
|
June 1, 1988
Mutagenicity of hexachloro-1,3-butadiene and its S-conjugates in the Ames test--role of activation by the mercapturic acid pathway in its nephrocarcinogenicity
S Vamvakas, F J Kordowich, W Dekant, et al.
Chemical Research in Toxicology
|
January 1, 1988
Cytotoxicity and bioactivation mechanism of benzyl 2-chloro-1,1,2-trifluoroethyl sulfide and benzyl 1,2,3,4,4-pentachlorobuta-1,3-dienyl sulfide
J C Veltman, W Dekant, F P Guengerich, et al.
Chemical Research in Toxicology
|
May 1, 1988
Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase
W Dekant, K Berthold, S Vamvakas, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 14, 2001
A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: implementing sensitivity and variability analyses
A C Licata, W Dekant, C E Smith, et al.
Page
of 199
Search research articles
Search
Showing results (111-120 of 1,990) with videos related to
Sort By:
Page
of 199
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1994
Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether
U Köster, P Speerschneider, R Kerssebaum, et al.
Chemical Research in Toxicology
|
July 22, 1998
Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1,2,3,4, 4-pentachlorobutadienyl)-L-cysteine sulfoxide
G Birner, M Werner, E Rosner, et al.
Chemico-Biological Interactions
|
August 14, 1992
Glutathione depletion, lipid peroxidation, DNA double-strand breaks and the cytotoxicity of 2-bromo-3-(N-acetylcystein-S-yl)hydroquinone in rat renal cortical cells
S Vamvakas, D Bittner, M Koob, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1994
Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)
G D Loizou, G Urban, W Dekant, et al.
Biochemical Pharmacology
|
January 15, 1986
Mutagenicity of chloroolefins in the Salmonella/mammalian microsome test--II. Structural requirements for the metabolic activation of non-allylic chloropropenes and methylated derivatives via epoxide formation
T Neudecker, W Dekant, M Jörns, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1987
Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation
W Dekant, G Martens, S Vamvakas, et al.
Carcinogenesis
|
June 1, 1988
Mutagenicity of hexachloro-1,3-butadiene and its S-conjugates in the Ames test--role of activation by the mercapturic acid pathway in its nephrocarcinogenicity
S Vamvakas, F J Kordowich, W Dekant, et al.
Chemical Research in Toxicology
|
January 1, 1988
Cytotoxicity and bioactivation mechanism of benzyl 2-chloro-1,1,2-trifluoroethyl sulfide and benzyl 1,2,3,4,4-pentachlorobuta-1,3-dienyl sulfide
J C Veltman, W Dekant, F P Guengerich, et al.
Chemical Research in Toxicology
|
May 1, 1988
Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase
W Dekant, K Berthold, S Vamvakas, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 14, 2001
A physiologically based pharmacokinetic model for methyl tert-butyl ether in humans: implementing sensitivity and variability analyses
A C Licata, W Dekant, C E Smith, et al.
Page
of 199